Related Experiment Video
Updated: Jun 3, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Influencing the Wnt signaling pathway in multiple myeloma
Young Kim1, Guido Reifenberger, Desheng Lu
1Department of Internal Medicine III, Center for Integrated Oncology, University of Bonn, Germany. Ingo.Schmidt-Wolf@ukb.uni-bonn.de
Abstract:
Recent studies have implicated genetic and epigenetic aberrations resulting in aberrant activation of the Wingless-Int (Wnt) pathway and thus influencing the initiation and progression of multiple myeloma (MM). Of major importance, these findings may lead to novel treatment strategies exploiting targeted modulation of Wnt signaling. This review describes the current status of knowledge concerning the role of Wnt pathway alteration in MM and outlines future lines of research and their clinical perspectives.
Insights
Aberrant activation of the Wingless-Int (Wnt) pathway, driven by genetic and epigenetic changes, fuels multiple myeloma (MM) development. Targeting Wnt signaling offers promising new therapeutic strategies for MM patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Multiple myeloma (MM) pathogenesis involves genetic and epigenetic alterations.
- The Wingless-Int (Wnt) signaling pathway plays a crucial role in cellular processes relevant to cancer.
- Aberrant Wnt pathway activation is increasingly recognized in various malignancies, including MM.
Purpose of the Study:
- To review the current understanding of Wnt pathway alterations in multiple myeloma.
- To explore the implications of Wnt signaling in MM initiation and progression.
- To outline future research directions and clinical perspectives for targeting Wnt in MM.
Main Methods:
- Literature review of recent studies on Wnt signaling in multiple myeloma.
- Analysis of genetic and epigenetic mechanisms affecting Wnt pathway activation.
- Synthesis of current knowledge on the role of Wnt in MM.
Main Results:
- Genetic and epigenetic aberrations frequently lead to aberrant Wnt pathway activation in MM.
- Wnt pathway dysregulation is implicated in the initiation and progression of multiple myeloma.
- Targeted modulation of Wnt signaling presents a potential therapeutic avenue for MM.
Conclusions:
- Wnt pathway alterations are significant drivers in multiple myeloma.
- Understanding these alterations is key to developing novel MM treatments.
- Targeting Wnt signaling holds promise for future MM therapeutic strategies.
More Related Videos
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
